Effect of antihypertensive therapy in preeclampsia on levels of serum interleukin-4

Gynecol Obstet Invest. 1996;42(4):230-6. doi: 10.1159/000291969.

Abstract

We investigated the effects of antihypertensive therapy on serum levels of interleukin-4 using InterTest-4 ELISA in 25 preeclamptic women; 14 were placed on treatment, while 11 were not. Comparison was made with 14 non-preeclamptic pregnant controls. Interleukin-4 levels were significantly lower in the controls than in the treated preeclamptic women (p < 0.001): 68.6 +/- 10.9 versus 106.1 +/- 13.2, 64.7 +/- 9.6 versus 119.8 +/- 11.4, 90.2 +/- 9.1 versus 124.3 +/- 15.7, and 65.6 +/- 3.6 versus 109.7 +/- 11.4 pg/ml, during antepartum, early intrapartum, late intrapartum and postpartum periods, respectively. No significant differences were detected between the therapy and no therapy subgroups (p > 0.05). This shows that antihypertensive therapy has no effect on interleukin-4 levels.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antihypertensive Agents / administration & dosage*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Hydralazine / administration & dosage
  • Infusions, Intravenous
  • Interleukin-4 / blood*
  • Interleukin-4 / physiology
  • Labetalol / administration & dosage*
  • Methyldopa / administration & dosage*
  • Pre-Eclampsia / blood*
  • Pre-Eclampsia / drug therapy
  • Pregnancy

Substances

  • Antihypertensive Agents
  • Interleukin-4
  • Hydralazine
  • Methyldopa
  • Labetalol